| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |